Blog
GE's Defense & Propulsion Unit Gains Momentum: Can It Sustain?
GE Aerospace GE is witnessing persistent strength in its Defense & Propulsion Technologies segment. Robust demand for the company’s propulsion & additive technologies, engines, critical aircraft
Tenet's 10.3% YTD Growth Beats S&P 500: Can Earnings Sustain the Pace?
Tenet Healthcare Corporation THC has extended its strong run into 2026, standing out as one of the better-performing names in the healthcare space. The stock has gained 10.3% year to date
Senseonics Reports Strong One-Year Real-World Data for Eversense 365
Senseonics Holdings, Inc. SENS recently presented first-ever real-world evidence for its Eversense 365 continuous glucose monitoring (CGM) system at the ATTD conference, highlighting strong
Avocado Supply Surge: How Mission Produce Capitalizes on Peru
Mission Produce, Inc. AVO is strategically capitalizing on the global surge in avocado supply, particularly from Peru and other major sourcing regions. The company is focused on boosting volume
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
Shares of CytomX Therapeutics CTMX soared 44.2% on Monday after the company reported positive phase I expansion data for its EpCAM-targeting PROBODY ADC, varsetatug masetecan (Varseta-M), in
AEIS Gains From Robust Industrial and Medical Segment: What's Ahead?
Advanced Energy AEIS has positioned itself as a key player in the industrial and medical markets, which are integral to its diversified business model. In the fourth quarter of 2025, revenues from
Post Holdings Pet Segment Volumes Dip: Recovery Signs Emerging?
Post Holdings, Inc.’s POST pet food business remained under pressure in the fiscal first quarter of 2026, standing out as one of the softer areas within Post Consumer Brands. The company’s pet
Here's How Astronics Can Retain Revenue Momentum Over the Long Term
Astronics Corporation ATRO has delivered steadily improving revenue growth, driven by recovering aerospace demand, a strong product portfolio, disciplined execution and structural enhancements
Are Options Traders Betting on a Big Move in Ridgepost Capital Stock?
Investors in Ridgepost Capital, Inc. RPC need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $05.00 Call had some of the highest
AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU
AstraZeneca AZN announced that the European Commission (EC) has approved its blockbuster cancer drug Imfinzi (durvalumab) as a perioperative treatment for early gastric and gastroesophageal junction
SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study
Shares of Sarepta Therapeutics SRPT rose about 2% yesterday after it announced that screening and enrollment are underway in cohort 8 of the phase Ib ENDEAVOR study.
This cohort is designed to
Semtech's Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
Semtech Corporation SMTC reported better-than-expected fourth-quarter fiscal 2026 results. It posted non-GAAP earnings of 44 cents per share, which beat the Zacks Consensus Estimate by a penny. The
KFS Stock Declines Post Q4 Earnings Despite Strong Revenue Growth
Shares of Kingsway Financial Services Inc. KFS have lost 2.8% since the earnings announcement for the period ended Dec. 31, 2025, compared with a 1.1% dip of the S&P 500 Index over the same
Is the Options Market Predicting a Spike in Cousins Properties Stock?
Investors in Cousins Properties, Incorporated CUZ need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $35.00 Call had some of the
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
The Zacks Medical – Outpatient and Home Healthcare industry is rapidly shifting toward digital modes of care delivery. In recent years, there has been a marked rise in demand for telemedicine
Flagstar Bank's Technology Expansion: A Step Toward Strategic Growth
In a significant step forward in its digital transformation journey, Flagstar Bank, N.A. FLG is expanding its technology leadership team. This move represents a long-term strategy aimed at
Is EMCOR's Capital Allocation Strategy Creating Shareholder Value?
EMCOR Group, Inc. EME has consistently emphasized a balanced capital allocation strategy and its 2025 performance suggests that this approach is paying off for shareholders. The company combines
Markets Wait for Fed's FOMC Meeting
It’s St Patrick’s Day, sure’n begorrah, and pre-market futures are fighting back into the green, where they closed Monday. Tensions regarding the Middle East in general and the Strait of Hormuz in
How Everpure is Leveraging Its Platform to Capture the AI Infra Boom
Per a report from Fortune Business Insights, the AI infrastructure market is estimated to go from $75.4 billion in 2026 to $497.98 billion by 2034 at a CAGR of 26.6%. Everpure PSTG recently upgraded
CALX Growth Drivers Investors Should Watch: BEAD, Gen3 and Agentic AI
Calix Inc. CALX is building a multi-year growth narrative around fiber-friendly policy, a third-generation platform transition, and a rising mix of recurring software tied to subscriber outcomes
Best Momentum Stocks to Buy for March 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 17:
Enerflex Ltd. EFXT: This energy solutions company has a Zacks Rank #1 and witnessed
5 Stocks With High ROE to Bet on as Oil Price Volatility Hits Markets
After a tumultuous past week, the broader equity markets witnessed an uptrend yesterday as oil prices cooled with the U.S. administration allowing Iranian oil tankers to pass safely through the
Earnings Preview: KB Home (KBH) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when KB Home (KBH) reports results for the quarter ended February 2026. While this widely-known consensus outlook is
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
vTv Therapeutics (VTVT) closed the last trading session at $38.13, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by


